Document is current
Any future updates will be listed below
-
Authors
Xitlally, Popa-Navarro
Alejandro, Avilés-Salas
Norma, Hernández-Pedro
Mario, Orozco-Morales
Enrique, Caballé-Pérez
Cesar, Castillo-Ruiz
José, Lucio-Lozada
Pedro, Barrios-Bernal
Juan-Manuel, Hernandez-Martinez
Oscar, Arrieta http://orcid.org/0000-0002-1164-3779
- License Information
-
More Information
Article History
Received: 25 March 2024
Accepted: 3 July 2024
First Online: 12 September 2024
Declarations
:
: This study was conducted in compliance with ethical standards stablished by the Declaration of Helsinki, and it was approved by the Ethics and Scientific Board Review Committee of the Instituto Nacional de Cancerología [(018/063(ICI) (CEI/1303/18)]..
: Written informed consent was not applicable.
: Oscar Arrieta reports receiving personal fees from Pfizer, Lilly, Merck, and Bristol-Myers Squibb and grants and personal fees from AstraZeneca, Boehringer Ingelheim, and Roche, outside of this submitted work. The rest of authors declare no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript.
